Actenol side effects

Question:

Can it be possible that actenol causes memory loss where the build-up in calcium gets in the brain such as harding of the arteries?

Answer:

Atonel is a brand of risedronate and is used to treat osteoporosis. The drug slows down cells that break down bone and allows cell that build bone to work better. Risedronate does not deposit calcium in the brain or in the arteries. Risedronate doesn’t generally effect memory. The link below can provide more information on risedronate.

Study Finds Flat Carbonated Beverages Ineffective For Hydration

An article published in the May issue of Archives of Disease in Childhood advises that children with acute vomiting and diarrhea should not use ‘flat’ carbonated beverages as an alternative for oral rehydration solution.

Patients with gastroenteritis (inflammation of the gastrointestinal tract) who are losing fluids, salts, and sugars due to diarrhea and vomiting typically ingest an oral rehydration solution that contains a certain balance of salts and sugars that can prevent dehydration. People often think that ‘flat’ carbonated beverages can be effective substitutes for these solutions – an especially appealing notion for children who are put off by the taste.

Important First Steps To Creating A Synthetic Copycat Of A Living Cell

Researchers at The University of Nottingham have taken some important first steps to creating a synthetic copycat of a living cell, a leading science journal reports.

Dr Cameron Alexander and PhD student George Pasparakis in the University’s School of Pharmacy have used polymers – long-chain molecules – to construct capsule-like structures that have properties mimicking the surfaces of a real cell.

In work published as a ‘VIP paper’ in the journal

Society Of Urologic Oncology Meeting – Repeat Prostate Biopsy – When, Where And How?

ORLANDO, FL (UroToday.com) – Dr. Presti discussed that the adequacy of the initial biopsy must be assessed. One must examine how many cores were taken on the first biopsy. If it was only 6 cores, there was a 40% chance of finding cancer on the second biopsy as compared to 24% when an extended pattern was initially performed. Prostate volume was also important: there was an inverse trend between size and detection. PSA indices are useful on repeat biopsy. Free/total PSA outperforms other indices such as PSAD-TZ or PSAD. PSA kinetics has not been shown to be too useful in detection on repeat prostate biopsy.

Two Years Of Quality Of Life Lost By Child Maltreatment Victims

Child maltreatment is associated with reductions in quality of life even decades later, according to a new University of Georgia study that finds that – on average – victims lose at least two years of quality of life.

UGA College of Public Health associate professor Phaedra Corso and her colleagues at the Centers for Disease Control and Prevention analyzed surveys of more than 6,000 people to assess the deficits in quality of life that victims suffer. Their results appear in the June issue of the

Patients With Stomach Cancer May Not Be Benefiting From A Major Study Showing Chemotherapy And Radiation Prolong Life After Surgery

New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer.

“We were surprised to learn that there are still many patients who are not receiving the gold standard of chemotherapy and radiation after surgery – despite compelling clinical data available since 2001. However, it is encouraging to see there has been a significant increase in the use of chemo-radiotherapy since it became the standard of care,” said Kristian Enestvedt, M.D., principal investigator, Department of Surgery, OHSU School of Medicine, OHSU Cancer Institute.

National Black Anti-Tobacco Group To Withdraw Support For Tobacco Regulation Bill Because Of Menthol ‘Loophole’

The National African-American Tobacco Prevention Network this week is expected to officially announce its withdrawal of support for legislation that would allow FDA to regulate flavored tobacco products other than menthol cigarettes, according to the group’s executive director, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 5/29).

The bill, sponsored by Sen. Edward Kennedy (D-Mass.) and 56 co-sponsors in the Senate, would give FDA the authority to remove addictive additives if they have proven to be harmful. Menthol-flavored products were excluded from the bill; such products represent more than 25% of the $70 billion tobacco market. Without the exclusion, the legislation might not have a chance of passing. The bill would also regulate advertisements and promotions for tobacco products.

Wireless Vision Implant

For twelve years, experts from different disciplines in the fields of microelectronics, neurophysics, information engineering, computer science, materials science and medicine have been working to develop a visual prosthetic device for patients who have lost their sight through diseases of the retina. In September 2007, their effort was rewarded. In a clinical study including six patients, the team was able to demonstrate not only that a completely implantable vision prosthesis is technically feasible and proven functioning, but also that it enables patients to perceive visual images. “For normally sighted people that may not seem much, but for the Blind, it is a major step,” comments Dr. Hoc Khiem Trieu from the Fraunhofer Institute for Microelectronic Circuits and Systems IMS in Duisburg. “After years of blindness, the patients were able to see spots of light or geometric patterns, depending on how the nerve cells were stimulated.” Dr. Hoc Khiem Trieu has been involved from the outset of this project, which was funded by the German Ministry of Education and Research. Together with Dr. Ingo Krisch and Dipl.-Ing. Michael Görtz he translated the specifications given by the medical experts and material scientists into an implant and chip design. The scientists are to receive the Joseph von Fraunhofer Prize 2008 for their work.

Grassley Inquiry Into Fast-Tracking Of Drug Applications Could Hurt Cancer Drug Development, Patients, Op-Ed States

Sen. Chuck Grassley’s (R-Iowa) request that the Government Accountability Office investigate whether FDA acted appropriately in granting “accelerated approval” to a cancer drug “will have a catastrophic effect on America’s ability to develop new drugs,” Mark Thornton, a former medical officer in FDA’s Office of Oncology Drug Products and president of the Sarcoma Foundation of America, writes in a Wall Street Journal opinion piece. The drug, Avastin, was granted accelerated approval for treating women with metastatic breast cancer after showing early evidence of an effect on the “surrogate endpoint” known as “progression-free survival,” according to Thornton.

JAMA Editorial, Commentary Discuss Effect Of Medical Spending On Health Outcomes, Preventive Health Efforts

“Spending on Medical Care: More Is Better?” Journal of the American Medical Association: The JAMA editorial by Gerard Anderson and Kalipso Chalkidou of the Johns Hopkins Bloomberg School of Public Health discusses studies that have examined whether increased spending on health care leads to better health outcomes. According to Anderson and Chalkidou, studies generally have not found a link between health spending levels and health outcomes, and factors such as education among women, average per capita income and degree of income inequality may better explain cross-national variation in overall health status than the level of health spending (Anderson/Chalkidou, JAMA, 5/28).